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Abstract
Background Recurrent attacks of acute biliary pancrea-
titis (RABP) are prevented by (laparoscopic)
cholecystectomy. Since the introduction of endoscopic
retrograde cholangiopancreaticography (ERCP), several
series have described a similar reduction of RABP after
endoscopic sphincterotomy (ES). This report discusses the
different treatment options for preventing RABP including
conservative treatment, cholecystectomy, ES, and combi-
nations of these options as well as their respective timing.
Methods A search in PubMed for observational studies
and clinical (comparative) trials published in the English
language was performed on the subject of recurrent acute
biliary pancreatitis and other gallstone complications after
an initial attack of acute pancreatitis.
Result Cholecystectomy and ES both are superior to
conservative treatment in reducing the incidence of RABP.
Cholecystectomy provides additional protection for gall-
stone-related complications and mortality. Observational
studies indicate that cholecystectomy combined with ES is
the most effective treatment for reducing the incidence of
RABP attacks.
Conclusion From the literature data it can be concluded
that ES is as effective in reducing RABP as cholecystec-
tomy but inferior in reducing mortality and overall
morbidity. The combination of ES and cholecystectomy
seems superior to either of the treatment methods alone. A
prospective randomized clinical trial comparing ES plus
cholecystectomy with cholecystectomy alone is needed.
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Acute biliary or gallstone pancreatitis (ABP) is an inflam-
matory condition of the pancreas induced by gallstones [1].
The initial treatment of ABP can be either conservative or
interventional. The coexistence of cholangitis is an accep-
ted indication for the performance of endoscopic retrograde
cholangiopancreaticography (ERCP). However, whether
this procedure is performed for patients with ABP depends
on local expertise and guidelines, as is the decision to
perform an endoscopic sphincterotomy (ES) [2–5].
After patients have recovered from their first attack of
ABP, most guidelines advocate a cholecystectomy to pre-
vent a recurrent attack or other gallstone-related disorders
such as symptomatic choledocholithiasis, cholecystitis,
gallstone ileus, jaundice, and cholangitis [2–5]. ‘‘Recur-
rent’’ symptomatic choledocholithiasis after an initial
attack of ABP may be preexisting common bile duct
(CBD) stones not detected at the time of the primo episode
or stones that migrated from the gallbladder into the CBD
after initial stone clearance. Choledocholithiasis also may
have developed newly within the bile duct after
cholecystectomy.
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The incidence of recurrent acute biliary pancreatitis varies
widely, from 0% to 57%, depending on the population
studied, the initial treatment, and the follow-up time
(Table 1). Recently, observational studies point toward a
reduction in recurrent ABP attacks and other gallstone
complications when ES is performed for selected groups of
patients [6–10]. Based on whether a patient has undergone
ES, cholecystectomy, or both, the post-ABP-status of a
patient can be classified into four categories: 1 (no ES and no
cholecystectomy), 2 (no ES with cholecystectomy), 3 (ES
without cholecystectomy), or 4 (ES with cholecystectomy).
To date, no studies have compared any combination of
these conditions (Table 1). The current report reviews
additional medical interventions to determine which are
most effective for preventing recurrent medical problems
after an attack of ABP.
Cholecystectomy versus conservative treatment
Evidence that a cholecystectomy actually reduces the
incidence of recurrent ABP is scarce. The evidence that
does exist originates mainly from older retrospective
studies that observed no recurrent ABP after a cholecys-
tectomy compared with a 25% to 61% rate of ABP
recurrence with conservative management [11–17]. From a
retrospective population-based cohort study, it was con-
cluded that a cholecystectomy reduces the risk of a
recurrent or de novo ABP almost to the same level as found
in the general population [18]. The overall age- and sex-
adjusted incidence of acute pancreatitis before cholecys-
tectomy was 6.3 to 14.8 per 1,000 patient years.
Cholecystectomy for patients without a prior ABP attack
reduced the relative risk for the development of acute
pancreatitis to 2 (0.65 per 1,000 person years). The
recurrence rate for acute pancreatitis of cholecystectomized
patients was 2.7 per 1,000 patient years. However, none of
these had a biliary origin. Importantly, 13% to 14% of all
patients presenting with ABP have a history of a prior
cholecystectomy without having undergone ERCP and ES
[19, 20].
Endoscopic sphincterotomy versus conservative
management
Uomo et al. [6] prospectively investigated the effect of ES
on patients after a first attack of ABP who were considered
unfit for surgery. In the ES group, the observed rate of
recurrent ABP was 5% compared with 57% in the con-
servative group after a mean follow-up period of 30 and
23.8 months, respectively. Paloyan et al. [21] confirmed
this rate of ABP recurrence after conservative treatment
with their rate of 48%. However, Hammarstrom et al. [8]
observed a 12.5% rate of ABP recurrence in nonchole-
cystectomized patients during a median follow-up period
of 79 months. Other prospective observational studies with
various follow-up times showed ABP recurrence rates of
0.9% to 6.4% for patients treated with ES alone [7, 8, 22–
24].
Intraoperative choledocholithiasis is present in 13% to
24% of patients undergoing cholecystectomy and bile duct
exploration for symptomatic gallstone disease [25–29],
including ABP [29, 30]. In 3% to 6% of the patients in
whom CBD stones were detected, the stones were
asymptomatic without preoperative indicators, negative
abdominal ultrasound findings, or laboratory parameters
[25, 29, 31]. It is believed that about 15% of these
asymptomatic patients eventually will become symptom-
atic and require further interventional treatment [32].
Table 1 Recurrent acute biliary pancreatitis (ABP)
Studya Recurrent
ABP % (n)
Recurrent ABP
after ES % (n)
Recurrent ABP after
cholecystectomy % (n)
Recurrent ABP after
cholecystectomy
and ES % (n)
Kaw, Billi, Hammarstrom, Vazquez-
Lglesias,Gislason [7, 8, 22–24]
0.9–6.4
Uomo [6] 57 (7) 5 (19)
Kaw [7] 2.9 (34) 2.4 (83)
Billi [22] 6.4 (47)
Hammarstrom [8] 12.5 (16) 2 (49) 19 (16) 0 (15)
Vazquez-Iglesias [23] 2.2 (88)
Paloyan [21] 48 (64)
Kahaleh [79] 2.1 (96) 3.0 (66)
ES endoscopic sphincterotomy
a All studies are prospective, observational, and nonrandomized
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Evaluation of the CBD for a planned cholecystectomy to
decide on CBD exploration should be scheduled with a
tight interval because the prevalence of CBD stones may
change in time. In fact, multiple studies have shown that
the prevalence of CBD stones in relation to admission time
decreases because of spontaneous stone migration [33–37]
(Table 2). Conversely, when a CBD is found to be free of
stones at admission, this might be not representative for the
time of surgery because migration of gallbladder stones
into the CBD may have occurred just before the operation.
From a clinical management point of view, patients
referred to the surgeon for a laparoscopic cholecystectomy
after an attack of ABP can be classified as follows
according to what is known about the presence of CBD
stones: 1 (cleared CBD after ERCP/ES), 2 (no CBD stones
on previous imaging investigations including ultrasound,
magnetic resonance cholangiopancreatography [MRCP],
endoscopic ultrasound [EUS], and ERCP), or 3 (unknown
CBD stone status). Hence, perioperative CBD stone
clearance is of great importance.
Clayton et al. [38] performed a metaanalysis to compare
endoscopic removal of CBD stones and cholecystectomy
with cholecystectomy and intraoperative removal of CBD
stones in terms of morbidity and mortality. They concluded
that both approaches had similar outcomes and that treat-
ment should be determined by local resources and
expertise.
Laparoscopic CBD duct exploration seems to be an ideal
approach, but most surgeons still are uncomfortable and
untrained with this technique. The potential drawback of
finding CBD stones intraoperatively is that conversion to
an open procedure sacrifices the advantage of the laparo-
scopic approach. However, a postoperative ERCP may be
unsuccessful in clearing the CBD, necessitating a second
surgical procedure. Adopting a wait-and-see policy is
associated with additional interventions and increased
morbidity [32, 39–41]. On the other hand, a ‘‘diagnostic’’
ERCP for detection and potential clearance of CBD stones
before surgery is not justified because 76% to 87% of
patients have no CBD stones, and the costs and potential
complications of such an invasive approach are consider-
able [25–29].
In light of these considerations, preoperative assessment
of CBD stones by means of noninvasive and cost-effective
procedures such as laboratory values, multi-item scores,
and imaging methods is of great clinical relevance. A wide
variety of multi-item scores are suggested to be useful, but
no two studies have identified the same variables. Factors
thought to be discriminative by some are found to be of
little use by others [41–63].
Recently, two studies assessed the value of gamma-
glutamyl-transferase (gGT) as a potential predictor for the
presence of CBD stones. Peng et al. [64] investigated
patients presenting with cholecystitis and found that there
was a 33% chance of concomitant CBD stones with a gGT
higher than 90 U/l and less than a 2% chance with a gGT
lower than 90 U/l. In 1,002 patients undergoing laparo-
scopic cholecystectomy for any reason, Yang et al. [65]
observed that abnormal gGT values had a sensitivity of
84.1%, a specificity of 72%, a positive predictive value of
22.4%, and a negative predictive value of 97.9% for
detecting concomitant CBD stones before surgery.
Radiologic imaging techniques also can be used to
detect CBD stones. Abdominal ultrasound is the safest,
cheapest, and least invasive imaging method available for
visualizing the biliary tree. Unfortunately, its performance
in detecting CBD stones is disappointing, with a reported
sensitivity of only 25% to 58% and a specificity of 68% to
91% [66]. The sensitivity of the CT scan for detecting CBD
stones is about 40%, which is too low for it to be of clinical
use [67]. However, MRCP is a very accurate method
detecting CBD stones, with a reported sensitivity of 82% to
95%, a specificity of 97.5% to100%, a positive predictive
value of 95% to100%, and a negative predictive value of
90% to 98% [33, 68–73].
In a systematic review of seven prospective trails, Le-
dro-Cano [74] compared the performance between MRCP
(n = 411) and endoscopic ultrasonography (n = 411) in
detecting choledocholithiasis. They concluded that both
imaging methods had a comparable and very high accuracy
in detecting CBD stones. Some individual studies suggest
that MRCP has a slightly lower sensitivity for detecting
stones than EUS because the sensitivity of MRCP
decreases as follows when stones become smaller: 67% to
100% for stones larger than 10 mm, 89% to 94% for stones
measuring 6 to 100 mm, and 33% to 71% for CBD stones
smaller than 6 mm [69–72]
Endoscopic sphincterotomy and cholecystectomy
Hammarstrom et al. [8] followed 96 patients after an initial
ABP event in an observational non randomized study for a
Table 2 Incidence of common bile duct (CBD) stones in acute bil-
iary pancreatitis (ABP) in relation to time [33–37]
Time from admission CBD stones (%)
Admission 50–70
\24 hours 45
\48 hours 27
2–3 days 23.1
4–5 days 25
6–7 days 12.5
[7 days 8
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median of 79 months (range, 33–168 months). From this
potentially biased study, it was concluded that ES without a
cholecystectomy reduced the overall incidence of recurrent
pancreatitis event (4.7% vs 9.4%; p = 0.02). Of those
patients initially treated using ES, 35% required an addi-
tional cholecystectomy during the follow-up period.
It is reported that 2% to 33% of patients with symp-
tomatic choledocholithiasis require an additional
cholecystectomy, suggesting that patients with ABP are at
greater risk for late gallstone-related complications [75–
77]. This also is supported by the observation that 15% of
the patients from the Hammarstrom study required an
emergency cholecystectomy after ES, compared with only
4% to 6% of patients presenting with symptomatic gall-
stone disease but not ABP [8, 75]. Higher cholecystectomy
rates probably are due to the risk of acute cholecystitis after
ES, which alone does not have a clear etiology [8, 78].
In a prospective nonrandomized trial, Kahaleh et al. [79]
investigated the rate of ABP recurrence after ES (n = 96)
compared with ES and cholecystectomy (n = 66). The
mean follow-up period was 1091 days. The observed rate
of ABP recurrence was 2.1% compared with 3%
(p = 0.278). Evidently, because of the nonrandomized
study design, selection bias cannot be ruled out. Further-
more, this study has been published only in abstract form
and other recurrent gallstone complications, for example,
are not discussed.
From the literature, the picture emerges that ES reduces
the number of recurrent ABP events more than a chole-
cystectomy. Does this mean that we can skip performing a
cholecystectomy after ABP? The answer is not straight-
forward. McAlister et al. performed a metaanalysis that
included five prospective randomized trials [9, 80–83]
showing the benefit of an additional cholecystectomy after
ES in case of symptomatic gallstone diseases, including
ABP [84]. An additional cholecystectomy resulted in a
lower death rate (7.9% vs 14.1%; p = 0.01) even in studies
that included patients from higher-risk American Society
of Anesthesiology (ASA) classes. In the patients for whom
a wait-and-see policy was adopted, 16% experienced the
development of biliary type pain or cholecystitis (relative
risk [RR], 14.56; confidence interval [CI], 4.95–42.78), and
more patients experienced recurrent jaundice or cholangitis
(RR, 2.53; CI, 1.09–5.87; p = 0.03), but no significant
difference in recurrent ABP rates was observed (0.3% vs
1.3%; p = 0.39). Eventually, for 35% of the patients
subjected to a wait-and-see policy, an additional chole-
cystectomy was performed, with median follow-up times
ranging from 30 to 80 months.
From these data, it seems apparent that a cholecystec-
tomy after an ABP event is beneficial and indicated. What
about the timing of the operation? No scientific data exist
to guide the timing of surgery. Expert opinion guidelines
are based on sound and practical reasoning. Windsor [17]
proposed that a cholecystectomy should be performed
within 1 month after the first episode of ABP because most
recurrent ABP events occur within 1 month (if no addi-
tional ES was performed). When the initial episode of ABP
is severe and accompanied by peripancreatic fluid collec-
tions or pseudocysts, cholecystectomy should be delayed
until the pseudocysts have either resolved or persisted
beyond 6 weeks, at which time pseudocyst drainage can
safely be combined with cholecystectomy [85].
Hammarstrom et al. [8] investigated the effect of an
additional ES after an initial cholecystectomy in preventing
recurrent ABP events. Their data showed a 0% rate for
recurrent ABP events after cholecystectomy plus ES
compared with a 19% rate for recurrent ABP events after
cholecystectomy alone and 2% after ES alone. These data
were not confirmed by Kahaleh et al. [79], who observed
no difference between ES and ES plus cholecystectomy in
preventing recurrent ABP (2.1% vs 3.0%). Furthermore,
the high rates of ABP recurrence after cholecystectomy in
the Hammarstrom et al. [8] study were not confirmed by
Kaw et al. [7], who reported a rate of 2.4%.
Boerma et al. [80] investigated the outcome of a cho-
lecystectomy for patients whose symptomatic CBD stones,
ABP, or both were treated by an ERCP and ES. The
patients were randomized into two groups: group 1 (ERCP
and ES plus cholecystectomy) and group 2 (ERCP and ES
plus a wait-and-see policy). They observed significantly
higher rates of conversion from laparoscopic to open pro-
cedure in the wait-and-see group than in the
cholecystectomy group (55% vs 20%; p = 0,01). This also
was observed by Allen et al. [86] in a prospectively col-
lected database (25% vs 4%; p \ 0.01). However, these
observations were not confirmed in the metaanalysis by
McAlister et al. described earlier.
Conclusion
Endoscopic sphincterotomy with or without an additional
cholecystectomy offers better protection than cholecys-
tectomy alone in terms of reducing the number of recurrent
ABP events. An additional cholecystectomy after ES is
indicated because studies suggest an added reduction in
mortality and morbidity. The proper timing of the chole-
cystectomy has not been studied and is based on expert
opinion. The current consensus is that surgery should be
used for mild cases during the same hospital admission and
severe cases after 6 weeks. To prevent recurrent ABP
events or other gallstone-related disease, CBD stone
clearance is an important issue. Therefore, diagnosing
CBD stones to establish the proper indication for ERCP
with ES and stone removal is an important and clinically
Surg Endosc (2009) 23:950–956 953
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relevant item. For this, MRCP and EUS are instrumental.
Randomized clinical trials comparing the long-term effects
of cholecystectomy and ES versus cholecystectomy alone
for APB are indicated.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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